A very recent meta-analysis study investigating AD association with BACE1 exon 5, demonstrated that the genotype CC+CT acts as a protective factor in ApoE4 carriers, and as a risk factor in apoE4 non-carriers [87]. This evidence concerns the gene APOE and Alzheimer disease.